NKp46 and NKG2D recognition of infected dendritic cells is necessary for NK cell activation in the human response to influenza infection

被引:153
|
作者
Draghi, Monia
Pashine, Achal
Sanjanwala, Bharati
Gendzekhadze, Ketevan
Cantoni, Claudia
Cosman, David
Moretta, Alessandro
Valiante, Nicholas M.
Parham, Peter
机构
[1] Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA
[2] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA
[3] Novartis Corp, Novartis Vaccines & Diagnost, Oakland, CA 94608 USA
[4] Amgen Inc, Dept Oncol, Seattle, WA 98101 USA
[5] Univ Genoa, Dept Expt Med, Ist Giannina Gaslini, Genoa, Italy
来源
JOURNAL OF IMMUNOLOGY | 2007年 / 178卷 / 05期
关键词
D O I
10.4049/jimmunol.178.5.2688
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
At an early phase of viral infection, contact and cooperation between dendritic cells (DCs) and NK cells activates innate immunity, and also influences recruitment, when needed, of adaptive immunity. Influenza, an adaptable fast-evolving virus, annually causes acute, widespread infections that challenge the innate and adaptive immunity of humanity. In this study, we dissect and define the molecular mechanisms by which influenza-infected, human DCs activate resting, autologous NK cells. Three events in NK cell activation showed different requirements for soluble mediators made by infected DCs and for signals arising from contact with infected DCs. IFN-alpha was mainly responsible for enhanced NK cytolysis and also important for CD69 up-regulation, whereas IL-12 was necessary for enhancing IFN-gamma production. Increased CD69 expression and IFN-gamma production, but not increased cytolysis, required recognition of influenza-infected DCs by two NK cell receptors: NKG2D and NKp46. Abs specific for these receptors or their known ligands (UL16-binding proteins 1-3 class I-like molecules for NKG2D and influenza hemagglutinin for NKp46) inhibited CD69 expression and IFN-gamma production. Activation of NK cells by influenza-infected DCs and polyinosinic:polycytidylic acid (poly(I:C) -treated DCs was distinguished. Poly(I:C)-treated DCs did not express the UL16-binding protein 3 ligand for NKG2D, and in the absence of the influenza hemagglutinin there was no involvement of NKp46.
引用
收藏
页码:2688 / 2698
页数:11
相关论文
共 50 条
  • [31] NKp46 and DNAM-1 NK-cell receptors drive the response to human cytomegalovirus-infected myeloid dendritic cells overcoming viral immune evasion strategies
    Magri, Giuliana
    Muntasell, Aura
    Romo, Neus
    Saez-Borderias, Andrea
    Pende, Daniela
    Geraghty, Daniel E.
    Hengel, Hartmut
    Angulo, Ana
    Moretta, Alessandro
    Lopez-Botet, Miguel
    BLOOD, 2011, 117 (03) : 848 - 856
  • [32] NKp46 and NKG2D receptor expression in NK cells with CD56dim and CD56bright phenotype:: regulation by histamine and reactive oxygen species
    Romero, A
    Thorén, F
    Movitz, C
    Betten, Å
    Hellstrand, K
    JOURNAL OF LEUKOCYTE BIOLOGY, 2005, : 69 - 69
  • [33] Interaction between human NK cells and bone marrow stromal cells induces NK cell triggering: Role of NKp30 and NKG2D receptors
    Poggi, A
    Prevosto, C
    Massaro, AM
    Negrini, S
    Urbani, S
    Pierri, I
    Saccardi, R
    Gobbi, M
    Zocchi, MR
    JOURNAL OF IMMUNOLOGY, 2005, 175 (10): : 6352 - 6360
  • [34] NKG2D is a key receptor for recognition of bladder cancer cells by IL-2-activated NK cells and BCG promotes NK cell activation
    Maria Garcia-Cuesta, Eva
    Lopez-Cobo, Sheila
    Alvarez-Maestro, Mario
    Esteso, Gloria
    Romera-Cardenas, Gema
    Rey, Mercedes
    Cassady-Cain, Robin L.
    Linares, Ana
    Vales-Gomez, Alejandro
    Thomson Reyburn, Hugh
    Martinez-Pineiro, Luis
    Vales-Gomez, Mar
    FRONTIERS IN IMMUNOLOGY, 2015, 6
  • [35] NKp46 and NKG2D Receptors Are Implicated in the Priming and Suppression of HIV Replication by Natural Killer Cells Stimulated by MVA/HIV ANRS Vaccine
    Cummings, J.
    Arnold, V.
    Didier, C.
    Gilbert, A.
    Yarbrough, K.
    Levy, Y.
    Barre-Sinoussi, F.
    Scott-Algara, D.
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2011, 27 (10) : A5 - A6
  • [36] A dual function of NKG2D ligands in NK-cell activation
    Cheney, Elizabeth E.
    Wise, Erica L.
    Bui, Jack D.
    Schreiber, Robert D.
    Carayannopoulos, Leonidas N.
    Spitzer, Dirk
    Zafirova, Biljana
    Polic, Bojan
    Shaw, Andrey S.
    Markiewicz, Mary A.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2012, 42 (09) : 2452 - 2458
  • [37] Modulation of NKG2D, NKp46, and Ly49C/I facilitates natural killer cell-mediated control of lung cancer
    Shi, Lei
    Li, Kang
    Guo, Yizhan
    Banerjee, Anirban
    Wang, Qing
    Lorenz, Ulrike M.
    Parlak, Mahmut
    Sullivan, Lucy C.
    Onyema, Oscar Okwudiri
    Arefanian, Saeed
    Stelow, Edward B.
    Brautigan, David L.
    Bullock, Timothy N. J.
    Brown, Michael G.
    Krupnick, Alexander Sasha
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2018, 115 (46) : 11808 - 11813
  • [38] Comparative analysis of human NK cell activation induced by NKG2D and natural cytotoxicity receptors
    André, P
    Castriconi, R
    Espéli, M
    Anfossi, N
    Juarez, T
    Hue, S
    Conway, H
    Romagné, F
    Dondero, A
    Nanni, M
    Caillat-Zucman, S
    Raulet, DH
    Bottino, C
    Vivier, E
    Moretta, A
    Paul, P
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2004, 34 (04) : 961 - 971
  • [39] NKG2D is the main receptor involved in NK cell activation against NKG2D ligand-positive melanoma cell lines
    Morgado, S.
    Sanchez-Correa, B.
    Casado, J. G.
    Gordillo, J.
    Gayoso, I.
    Duran, M. E.
    Solana, R.
    Tarazona, R.
    IMMUNOLOGY, 2012, 137 : 242 - 242
  • [40] NKG2D is critical for NK cell activation in host defense against Pseudomonas aeruginosa respiratory infection
    Wesselkamper, Scott C.
    Eppert, Bryan L.
    Motz, Gregory T.
    Lau, Gee W.
    Hassett, Daniel J.
    Borchers, Michael T.
    JOURNAL OF IMMUNOLOGY, 2008, 181 (08): : 5481 - 5489